These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 36130796)

  • 1. Adapting public health response through lessons learnt: Nigeria's experience from Lassa fever and COVID-19.
    Saleh F; Popoola BO; Arinze C; Elisha AA; Dan-Nwafor C; Olajide L; Ilori E; Ochu CL; Ihekweazu CA
    BMJ Glob Health; 2022 Sep; 7(Suppl 7):. PubMed ID: 36130796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COVID-19 and Lassa fever in Nigeria: A deadly alliance?
    Musa SS; Zhao S; Abdullahi ZU; Habib AG; He D
    Int J Infect Dis; 2022 Apr; 117():45-47. PubMed ID: 35108609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is the COVID-19 pandemic masking the deadlier Lassa fever epidemic in Nigeria?
    Reuben RC; Danladi MMA; Pennap GR
    J Clin Virol; 2020 Jul; 128():104434. PubMed ID: 32434707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deadly Lassa-fever outbreak tests Nigeria's revamped health agency.
    Maxmen A
    Nature; 2018 Mar; 555(7697):421-422. PubMed ID: 29565399
    [No Abstract]   [Full Text] [Related]  

  • 5. Nigeria's unending war with Lassa fever.
    Adepoju P
    Lancet; 2019 Feb; 393(10172):627-628. PubMed ID: 30833112
    [No Abstract]   [Full Text] [Related]  

  • 6. Measures to control protracted large Lassa fever outbreak in Nigeria, 1 January to 28 April 2019.
    Dan-Nwafor CC; Furuse Y; Ilori EA; Ipadeola O; Akabike KO; Ahumibe A; Ukponu W; Bakare L; Okwor TJ; Joseph G; Mba NG; Akano A; Olayinka AT; Okoli I; Okea RA; Makava F; Ugbogulu N; Oladele S; Namara G; Muwanguzi EN; Naidoo D; Mutbam SK; Okudo I; Woldetsadik SF; Lasuba CL; Ihekweazu C
    Euro Surveill; 2019 May; 24(20):. PubMed ID: 31115314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Research as a pillar of Lassa fever emergency response: lessons from Nigeria.
    Olayinka AT; Nwafor CD; Akano A; Jan K; Ebhodaghe B; Elimian K; Ochu C; Okwor T; Ipadeola O; Ukponu W; Okudo I; Peter C; Ilori E; Ihekweazu C
    Pan Afr Med J; 2020; 37():179. PubMed ID: 33447334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Re-emerging Lassa fever outbreaks in Nigeria: Re-enforcing "One Health" community surveillance and emergency response practice.
    Tambo E; Adetunde OT; Olalubi OA
    Infect Dis Poverty; 2018 Apr; 7(1):37. PubMed ID: 29703243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lassa fever amidst the COVID-19 pandemic in Africa: A rising concern, efforts, challenges, and future recommendations.
    Uwishema O; Alshareif BAA; Yousif MYE; Omer MEA; Sablay ALR; Tariq R; Zahabioun A; Mwazighe RM; Onyeaka H
    J Med Virol; 2021 Dec; 93(12):6433-6436. PubMed ID: 34289134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A cluster of nosocomial Lassa fever cases in a tertiary health facility in Nigeria: Description and lessons learned, 2018.
    Dan-Nwafor CC; Ipadeola O; Smout E; Ilori E; Adeyemo A; Umeokonkwo C; Nwidi D; Nwachukwu W; Ukponu W; Omabe E; Anaebonam U; Igwenyi N; Igbodo G; Eteng W; Uzoma I; Saleh M; Agboeze J; Mutbam S; de Gooyer T; Short R; Aniaku E; Onoh R; Ogah E; Nguku P; Oladejo J; Peter C; Ojo O; Ihekweazu C
    Int J Infect Dis; 2019 Jun; 83():88-94. PubMed ID: 30930184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lessons from Nigeria's Adaptation of Global Health Initiatives during the COVID-19 Pandemic.
    Ihekweazu C
    Emerg Infect Dis; 2022 Dec; 28(13):S299-S301. PubMed ID: 36502443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preventive practices by households against Lassa fever transmission in Ondo State, Southwest, Nigeria.
    Isere EE; Fatiregun AA; Omorogbe NE; Oluwole MT
    Pan Afr Med J; 2022; 43():176. PubMed ID: 36879638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outbreak of lassa fever in Nigeria: measures for prevention and control.
    Mofolorunsho KC
    Pan Afr Med J; 2016; 23():210. PubMed ID: 27347299
    [No Abstract]   [Full Text] [Related]  

  • 14. Improving Cross-Border Preparedness and Response: Lessons Learned from 3 Lassa Fever Outbreaks Across Benin, Nigeria, and Togo, 2017-2019.
    Kakaī CG; Okunromade OF; Dan-Nwafor CC; Chabi AIB; Martial GTP; Dalhat MM; Ward S; Tante O; Nguku PM; Hamadi A; Ilori E; Lokossou V; Brito C; Ojo OE; Kone I; Agbeko TT; Ihekweazu C; Merrill RD
    Health Secur; 2020 Jan; 18(S1):S105-S112. PubMed ID: 32004125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implementing an emergency risk communication campaign in response to the COVID-19 pandemic in Nigeria: lessons learned.
    Ihekweazu V; Ejibe U; Kaduru C; Disu Y; Oyebanji O; Oguanuo E; Anueyiagu C; Obanor OO; Akande-Alegbe A; Egwuenu A; Ojumu T; Abara AE; Ochu CL
    BMJ Glob Health; 2022 Jun; 7(6):. PubMed ID: 35675971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rising cholera cases: Harnessing the momentum of COVID-19 to strengthen Nigeria's health systems.
    Oladapo RK; Oyetola AB; Obidiro OP; Olajide A; Osuagwu-Nwogu E; Olaitan OM; Ngokere C; Monisola I; Ibraheem B; Afolayan A
    Int J Health Plann Manage; 2021 Nov; 36(6):2030-2034. PubMed ID: 34296467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increase in Lassa Fever Cases in Nigeria, January-March 2018.
    Ilori EA; Frank C; Dan-Nwafor CC; Ipadeola O; Krings A; Ukponu W; Womi-Eteng OE; Adeyemo A; Mutbam SK; Musa EO; Lasuba CLP; Alemu W; Okogbenin S; Ogbaini E; Unigwe U; Ogah E; Onoh R; Abejegah C; Ayodeji O; Ihekweazu C
    Emerg Infect Dis; 2019 May; 25(5):1026-1027. PubMed ID: 30807268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Knowledge of Lassa fever, its prevention and control practices and their predictors among healthcare workers during an outbreak in Northern Nigeria: A multi-centre cross-sectional assessment.
    Wada YH; Ogunyinka IA; Yusuff KB; Ochu CL; Yahaya M; Khalid GM; Mutalub YB; Adeniye SB
    PLoS Negl Trop Dis; 2022 Mar; 16(3):e0010259. PubMed ID: 35286303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lessons from co-production of evidence and policy in Nigeria's COVID-19 response.
    Abubakar I; Dalglish SL; Ihekweazu CA; Bolu O; Aliyu SH
    BMJ Glob Health; 2021 Mar; 6(3):. PubMed ID: 33741561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Origins and Future of Sentinel: An Early-Warning System for Pandemic Preemption and Response.
    Botti-Lodovico Y; Nair P; Nosamiefan D; Stremlau M; Schaffner S; Agignoae SV; Aiyepada JO; Ajogbasile FV; Akpede GO; Alhasan F; Andersen KG; Asogun DA; Ayodeji OO; Badiane AS; Barnes K; Bauer MR; Bell-Kareem A; Benard ME; Benevolence EO; Blessing O; Boehm CK; Boisen ML; Bond NG; Branco LM; Butts MJ; Carter A; Colubri A; Deme AB; DeRuff KC; Diédhiou Y; Edamhande AP; Elhamoumi S; Engel EJ; Eromon P; Fallah M; Folarin OA; Fry B; Garry R; Gaye A; Gbakie M; Gevao SM; Gionet G; Gladden-Young A; Goba A; Gomis JF; Happi AN; Houghton M; Ihekwuazu C; Iruolagbe CO; Jackson J; Jalloh S; Johnson J; Kanneh L; Kayode A; Kemball M; Kingsley OC; Koroma V; Kotliar D; Mehta S; Metsky HC; Michael A; Mirhashemi ME; Modjarrad K; Momoh M; Myhrvold CA; Naregose OG; Ndiaye T; Ndiaye M; Ndiaye A; Normandin E; Odia I; Oguzie JU; Okogbenin SA; Okokhere PO; Okolie J; Olawoye IB; Olumade TJ; Oluniyi PE; Omoregie O; Park DJ; Paye MF; Petros B; Philippakis AA; Priscilla A; Ricks A; Rimoin A; Sandi JD; Schieffelin JS; Schreiber M; Seck MC; Siddiqui S; Siddle K; Smither AR; Sy M; Sy N; Tomkins-Tinch CH; Tomori O; Ugwu C; Uwanibe JN; Uyigue EA; Victoria DI; Vinzé A; Vodzak ME; Welch N; Wurie HI; Zoumarou D; Grant DS; Ndiaye D; MacInnis B; Sabeti PC; Happi C
    Viruses; 2021 Aug; 13(8):. PubMed ID: 34452470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.